Personal tools

MCL coexpression mm9:1410: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!1.45e-26!75;UBERON:0001017!6.62e-26!73;UBERON:0004121!1.06e-20!95;UBERON:0000924!1.06e-20!95;UBERON:0006601!1.06e-20!95;UBERON:0002346!3.71e-20!64;UBERON:0003075!3.71e-20!64;UBERON:0007284!3.71e-20!64;UBERON:0000073!1.66e-19!54;UBERON:0001049!1.96e-18!52;UBERON:0005068!1.96e-18!52;UBERON:0006241!1.96e-18!52;UBERON:0007135!1.96e-18!52;UBERON:0000955!2.52e-15!47;UBERON:0006238!2.52e-15!47;UBERON:0002616!4.50e-15!46;UBERON:0010371!7.62e-15!73;UBERON:0010314!1.53e-14!92;UBERON:0003056!3.70e-14!49;UBERON:0002020!1.01e-13!34;UBERON:0003080!1.33e-12!40;UBERON:0002780!2.90e-12!39;UBERON:0001890!2.90e-12!39;UBERON:0006240!2.90e-12!39;UBERON:0003528!8.17e-11!29;UBERON:0002791!8.17e-11!29;UBERON:0001893!8.17e-11!29;UBERON:0000956!6.00e-07!21;UBERON:0001869!6.00e-07!21;UBERON:0000203!6.00e-07!21;UBERON:0003076!8.04e-07!12;UBERON:0003057!8.04e-07!12
|ontology_enrichment_uberon=UBERON:0001016!1.45e-26!75;UBERON:0001017!6.62e-26!73;UBERON:0004121!1.06e-20!95;UBERON:0000924!1.06e-20!95;UBERON:0006601!1.06e-20!95;UBERON:0002346!3.71e-20!64;UBERON:0003075!3.71e-20!64;UBERON:0007284!3.71e-20!64;UBERON:0000073!1.66e-19!54;UBERON:0001049!1.96e-18!52;UBERON:0005068!1.96e-18!52;UBERON:0006241!1.96e-18!52;UBERON:0007135!1.96e-18!52;UBERON:0000955!2.52e-15!47;UBERON:0006238!2.52e-15!47;UBERON:0002616!4.50e-15!46;UBERON:0010371!7.62e-15!73;UBERON:0010314!1.53e-14!92;UBERON:0003056!3.70e-14!49;UBERON:0002020!1.01e-13!34;UBERON:0003080!1.33e-12!40;UBERON:0002780!2.90e-12!39;UBERON:0001890!2.90e-12!39;UBERON:0006240!2.90e-12!39;UBERON:0003528!8.17e-11!29;UBERON:0002791!8.17e-11!29;UBERON:0001893!8.17e-11!29;UBERON:0000956!6.00e-07!21;UBERON:0001869!6.00e-07!21;UBERON:0000203!6.00e-07!21;UBERON:0003076!8.04e-07!12;UBERON:0003057!8.04e-07!12
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.217198,0.464605,0.535892,0.346849,0.550971,0.645383,0.247459,0.257202,1.00112,0.599767,0.632897,1.28144,0.6581,0.364314,0,0.856992,0.338549,0.232269,0.143775,0.426133,0.108444,1.58083,0.345236,0.472505,0.686615,0.223823,0.572827,0.394364,0.181062,0.558142,0.960397,0.336199,0.589948,0.364821,0.144368,1.56842,0.629145,0.303703,0.27383,0.342638,0.56353,0.0995018,0.366415,0.659176,0.524258,0.77511,0.589246,0.0835644,0.397446,0.839084,0.714419,0.174327,2.49807,1.12205,0.66551,0.406788,0.619643,0.21472,0.663395,0.939962,0.724164,0.269393,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.253541,0.740068,1.156,1.13013,1.08629,0.204132,0.763395,0.922432,0.430551,0.254777,2.03037,0.722675,0.676326,1.03903,0.439832,0.0610418,0.181203,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.281222,0.244935,0.976308,0.775372,0.483322,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,0.484547,1.0885,0.431734,0.605144,1.33732,0.90315,0.528609,0.53982,0.858327,0.322606,1.16147,0.805995,1.6461,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,1.62768,1.35909,0.347287,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.348692,0.540361,0.667976,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.325308,0.63125,0.5667
}}
}}

Revision as of 19:52, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr18:35931330..35931364,+p2@Ube2d2
Mm9::chr5:138220099..138220163,+p1@Ppp1r35
Mm9::chr6:113573982..113574031,+p1@Vhl
Mm9::chr8:74763951..74764080,+p1@Ap1m1
Mm9::chr8:97190514..97190550,+p1@Arl2bp
Mm9::chr8:97190552..97190576,+p2@Arl2bp


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0030163protein catabolic process0.0343445343924042
GO:0043534blood vessel endothelial cell migration0.0343445343924042
GO:0043285biopolymer catabolic process0.0343445343924042
GO:0009057macromolecule catabolic process0.0343445343924042
GO:0043542endothelial cell migration0.0343445343924042



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
nervous system1.45e-2675
central nervous system6.62e-2673
ectoderm-derived structure1.06e-2095
ectoderm1.06e-2095
presumptive ectoderm1.06e-2095
neurectoderm3.71e-2064
neural plate3.71e-2064
presumptive neural plate3.71e-2064
regional part of nervous system1.66e-1954
neural tube1.96e-1852
neural rod1.96e-1852
future spinal cord1.96e-1852
neural keel1.96e-1852
brain2.52e-1547
future brain2.52e-1547
regional part of brain4.50e-1546
ecto-epithelium7.62e-1573
structure with developmental contribution from neural crest1.53e-1492
pre-chordal neural plate3.70e-1449
gray matter1.01e-1334
anterior neural tube1.33e-1240
regional part of forebrain2.90e-1239
forebrain2.90e-1239
future forebrain2.90e-1239
brain grey matter8.17e-1129
regional part of telencephalon8.17e-1129
telencephalon8.17e-1129
cerebral cortex6.00e-0721
cerebral hemisphere6.00e-0721
pallium6.00e-0721
posterior neural tube8.04e-0712
chordal neural plate8.04e-0712


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}